Pembrolizumab with or Without Lenvatinib As First-line Therapy for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC): Phase 3 LEAP-010 Study

L. Licitra,M. Tahara,K. Harrington,M. Olivera Hurtado de Mendoza,Y. Guo,S. Aksoy,M. Fang,B. Żurawski,T. Csőszi,M. Klochikhin,T.B. de Oliveira, S. Takahashi,M.H. Yang,P.L. Swiecicki, K. O'Hara, J. Shen, A. Wang,B. Gumuscu, K. Benjamin,R.I. Haddad

International Journal of Radiation OncologyBiologyPhysics（2024）

引用 0|浏览16

暂无评分

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要